Клиническая характеристика и лечение неинвазивных и минимальных инвазивных форм рака молочной железы
Диссертация
Как известно, выживаемость напрямую зависит как от выбора правильного лечения, так и от стадии заболевания. 5-летняя выживаемость больных с IV стадией РМЖ не превышает 10%, в то время как при I стадии 90−95% переживают 5-летний срок после операции (В.М.Моисеенко, 1997; В. П. Летягин, 2004). Показатели общей выживаемости больных с неинвазивным раком молочной железы при условии адекватного лечения… Читать ещё >
Содержание
- Глава I.
- Обзор литературы
- Глава II.
- Материалы и методы
- Глава III.
- Алгоритм диагностики непальпируемых форм рака молочной железы
- Глава IV.
- Лечение неинвазивных форм рака молочной железы
- Значение объема оперативного вмешательства в лечении неинвазивных и минимальных инвазивных форм рака молочной железы
- Эффективность лучевой терапии при лечении неинвазивных форм рака молочной железы
- Эффективность гормонотерапии при лечении неинвазивных форм рака молочной железы
- Факторы риска развития рецидивов при неинвазивном раке молочной железы
- Значение патоморфологических признаков
- Степень гистологической злокачественности
- Размер первичной опухоли
- Прогностическая значимость HER-2/пеи статуса. Ю
- ГЛАВА V.
- Минимальный инвазивный рак
- Лучевая терапия
- Химотерапия
- Гормонотерапия
Список литературы
- Бавли Я.Л. Возможности клинического выявления ранних форм рака молочной железы // Ранняя диагностика рака молочной железы.-Ленинград, 1980.-С. 56−61.
- Баженова А.П. Выбор объема хирургического вмешательства при раке молочной железы // Хирургия.-1978.-N 6.-С. 136−141.
- Баженова А.П., Островцев Л. Д., Хаханашвили Г. Н. Рак молочной железы.-М:Медицина, 1985.-272 с.
- Берштейн Л.М. Онкоэндокринология. Традиции, современность и перспективы//СПб:Наука, 2004.-343 с.
- Быстрова В.Б. Вопросы гистологии и дифференциальной диагностики лобулярного рака in situ молочной железы // Арх. naT.-1972.-N 8-С. 64−68.
- Веснин А.Г. Лучевая диагностика рака молочной железы//В кн. Семиглазов В. Ф., Нургазиев К. Ш., Арзуманов А. С. Опухоли молочной железы (лечение и профилактика).-Алматы, 2001.- с. 98 102.
- Веснин А.Г., Зайцев А. Н., Чебыкин И. А., Черномордикова М. Ф. Сравнительная оценка эффективности эхографии и рентгенографии молочных желез//Актуальные проблемы профилактики и лечения рака молочной железы.-Санкт-Петербург.-1993 .-с. 21−22.
- Возный Э.К. Адъювантная химиотерапия рака молочной железы: от алкилирующих препаратов и антиметаболитов кантрациклинами таксанам // Современная онкология.-2001 .-N 2.-С. 72−74.
- Гарин A.M. Принципы о возможности современной эндокринотерапии опухолей // М.-2000.-207 с.
- Герштейн Е.С., Кушлинский Н. Е. Молекулярные маркеры прогноза и лекарственной чувствительности рака молочной железы // Новое в терапии рака молочной железы.-Под редакцией Переводчиковой Н.И.-М.-1998.-С. 19−24.
- Гольберт З.В., Островцев Л. Д., Соркин Э. Е. О раннем и «скрытом» раке молочной железы // Вопр. онкол.-1981.^ 10.- С. 34−39.
- Демидов В.П., Островцев Л. Д., Пак Д.Д. и др. Диагностика и лечение ранних форм рака молочной железы//1У Всесоюзный съезд онкологов.-Л.-1986.- с. 251−252.
- Демин В. Н. Лечение рака молочной железы// Хирургия.-1977.-№ 2.-С. 23−26.
- Дымарский Л.Ю. Рак молочной железы.-М.: Медицина, 1980.-192 с.
- Заридзе Д.Г. Эпидемиология и скрининг рака молочной железы // Вопр. онкол.-2002.- том 48.-С. 489−495.
- Заридзе Д.Г., Яковлева Е. Э. Профилактика рака молочной железы //Вопр. Онкол.-1989.-К 5.-С. 519−528.
- Иванов В.Г. Адъювантное лечение рака молочной железы (по материалам конференции в Сант-Галлене) // Материалы VII российского онкол. конгресса.-Москва, 2003.-С. 97−100.
- Канаев С.В. Место лучевой терапии при органосохраняющих операциях на молочной железе// Первая международная ежегодная онкологическая конференция «Проблемы диагностики и лечения рака молочной железы». -Санкт-Петербург.- 2004.
- Канаев С.В., Семиглазов В. Ф., Бугрова И. Л. и др. Роль лучевой терапии при органосохраняющих операциях у больных раком молочной железы//Ш Ежегодная Российская онкологическая конференция.-Санкт-Петербург.-1999.- с. 128.
- Кудрявцев Д.В., Гуменецкая Ю. В. Лучевая терапия больных раком молочной железы // Материалы V ежегодной российской онкол. конференции.-Москва, 2001.-108 с.
- Летягин В.П. Первичный рак молочной железы (диагностика, лечение, прогноз) / Летягин В. П., В. И. Высоцкая.-М.-1998.-С. 3235.
- Летягин В.П. Современные подходы к лечению первичного рака молочной железы//Ш съезд онкологов и радиологов СНГ.-Минск.-2004.- с. 103−110.
- Летягин В.П. Современные подходы к лечению рака молочной железы // Вопр. онкол.- 1985.-N 8.- С. 108−110.
- Ли Л. А. Мнение онколога о доброкачественных заболеваниях молочных желез // Материалы Первой международной ежегодной онкологической конференции «Проблемы диагностики и лечения рака молочной железы».-СПб, 2004.-С. 78−80.
- Мартынюк В.В. Экономные операции при раке молочной железы (РМЖ) // Материалы Первой международной ежегоднойонкологической конференции «Проблемы диагностики и лечения рака молочной железы».-СПб, 2004.-129 с.
- Моисеенко В.М. Клиническое значение прогностических факторов при раке молочной железы // Новое в терапии рака молочной железы.-Под редакцией Переводчиковой Н.И.-М.-1998.-С. 25−31.
- Моисеенко В.М., Семиглазов В. Ф., Тюляндин С. А. Современное лекарственное лечение местно-распространенного и метастатического рака молочной железы//СПб:Грифон, 1997.-254 с.
- Нейштадт Э.Л. Мастопатия. Есть ли повод для беспокойства? // Материалы Первой международной ежегодной онкологической конференции «Проблемы диагностики и лечения рака молочной железы».-СПб, 2004.-С. 80−82.
- Нейштадт Э.Л., Воробьева О. А. Патология молочной железы.-СПб.: Фолиант, 2003.-208 с.
- Онкологическая служба Санкт-Петербурга//Под редакцией проф. В. М. Мерабишвили.-СПб: Издательство Медицинская пресса, 2003.- 144 с.
- Орлов А.А., Семиглазов В. Ф., Черномордикова М. Ф. и соавт. Выявление минимальных форм рака молочной железы (докл.)//Вопр.онкол.-1985.-№ 4.-С. 104−105.
- Пак Д.Д., Евтягин В. В., Сарибекян Э. К. и др. Органосохраняющие и одномоментные реконструктивно-пластические операции при раке молочной железы // Вопр. Om"wi.-2002.-N 4.-С. 615−619.
- Пак.Д. Д. Эволюция хирургического лечения рака молочной железы: от расширенных мастэктомий до органосохраняющего лечения//У Российская онкологическая конференция.-Москва.-2001.- с.21−30.
- Переводчикова Н.И. Новое в терапии рака молочной железы // Под редакцией Переводчиковой Н.И.-М.-1998.-91 с.
- Пожарисский К.М. Прогностические и предсказывающие гистохимические критерии в онкологии // Арх. патол.- 2000.-N3.-С.193−214.
- Портной С.М., Лактионов К. П., Барканов А. И. и др. Эффективность органосохраняющих операций при раке молочной железы ТШ0М0//Вопр.онкол.-1998.-№ 4.-с. 439−442.
- Рожкова Н.И. Рентгенодиагностика заболеваний молочных желез//М.: Медицина.-1993.- 24 с.
- Семиглазов В.Ф., Орлов А. А., Кучиеру А. Г. и др. Вторичная профилактика рака молочной железы//Патогенетические подходы к профилактике и лечению гормонозависимых опухолей/ Под ред. Н. П. Напалкова и др.-Л., 1983.-С. 38−44.
- Семиглазов В.Ф. Ранняя диагностика опухолей молочной железы.-Ташкент: Медицина, 1989.-184 С.
- Семиглазов В.Ф., Веснин А. Г., Моисеенко В. М. Минимальный рак молочной железы.-СПб: Гиппократ, 1992.-240 с.
- Семиглазов В.Ф., Канаев С. В., Пожарисский К. П. и др Органосохраняющее лечение ранних стадий инвазивного рака молочной железы (pTl-2N0M0) /Метод. рек.-СПб, 2001.-13 с.
- Семиглазов В.Ф., Орлов А. А. Клиника и лечение «минимальных» форм рака молочной железы//Вопр. онкол.-1983.-№ 5.-с. 28−33.
- Сидоренко JI.H. Гормонотерапия предрака и рака молочной железы.-JI, 1986,-224.
- Старинский В.В., Петрова Г. В., Харченко Н. В. и др. Заболеваемость злокачественными новообразованиями в России в 2000 году / // Тез. Всерос. Симпозиума с международным участием «Новые технологии в онкологической статистике».-СПб, 2001.-С. 17−32.
- Трапезников Н.Н., Летягин В. П., Алиев Д. А. Лечение рака молочной железы // М.: Медицина, 1989.-175 с.
- Тюляндин С.А. Системная терапия операбельного рака молочной железы // Практическая онкология.-2002.-Том 3.-N 1.-С. 29−38.
- Франк Г. А., Волченко Н. Н. Морфологическая диагностика и прогноз при начальном протоковом раке молочной железы // Вопр. онкол.- 1992.-N 5.- С. 299−309.
- Харченко В.П., Рожкова Н. И. Развитие маммологической службы Российской Федерации// III съезд онкологов и радиологов СНГ.-Минск.-2004.- с. 81−83.
- Чагунава O.JI. Сберегательные и органосохраняющие операции при раке молочной железы Т1−21М0М0//Актуальные проблемы профилактики и лечения рака молочной железы.-Санкт-Петербург.-1993.
- Чиссов В.И. Пути развития органосохраняющего лечения в онкологии // Материалы III съезда онкологов и радиологов СНГ.-Минск, 2004.-Часть 1.-С. 42−46.
- Adamovich TL, Simmons RM. Ductal carcinoma in situ with microinvasion. Am J Surg. 2003 Aug- 186(2): 112−6.
- Allred D., Bryant J., Land S., et al. Estrogen receptor expression as a predictive marker of effectiveness of tamoxifen in the treatment of DCIS: Findings from NSABP protocol B- 24 // Breast Cancer Res. Treat.- 2003.-Vol. 76 (Suppl. 1).-P. 36.
- Amichetti M., Caffo O., Richetti A., et al. Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy // Eur. J. Cancer.-1997.-Vol. 33.-P. 15 591 565.
- Andersen J.A., Fechner R.E., Lattes R. et al. Lobular carcinoma in situ (lobular neoplasia) of the breast // Pathol. Ann.-1980.-Vol. 15.-P. 193 223.
- Arnesson L.G., Olsen K. Linkoping experience // Silverstein M.J. (Ed.) Ductal carcinoma in situ of the breast.-Baltimore: Williams and Wilkins, 1997.-P. 373−378.
- Arnesson L.G., Smeds S., Fagerberg G., et al. Follow-up of two treatment modalities for ductal carcinoma in situ of the breast // Br. J. Surg.-1989.-Vol. 76.-P. 672−675.
- Arriagada R., Le M.G., Rochard F., et al. Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data. Institute Gustave-Roussy Breast Cancer Group //J. Clin. Oncol.-1996.-Vol. 14.-P. 1558−1564.
- Ashikari R., Hajdu S.I., Robbins G.F. Intraductal carcinoma of the breast (1960−1969) // Cancer.-1971.-Vol. 28.-P. 1182−1187.
- Azavedo E., Svane G., Auer G. Stereotactic fine needle biopsy in 2594 mammographically detected non-palpable lesions//Lancet.-1989.-Vol.i.-P.1033−1035.
- Badve S., A’Hern R.P., Ward A.M., et al. Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-up // Hum. Pathol.-1998.-Vol. 29.-P. 915−923.
- Baird R.M., Worth A., Hislop G. Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast // Am. J. Surg.-1990.-Vol. 159.-P. 479−481.
- Bames D.M., Meyer J.S., Gonzalez J.G., et al. Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ // Breast Cancer Res. Treat.-1991.-Vol. 18.-P. 11−17.
- Bassett L., Winchester D.P., Caplan R.B., et al. Stereotactic core-needle biopsy of the breast: a report of the Joint Task Force of the
- American College of Radiology, American College of Surgeons and College of American Pathologists//CA Cancer J. Clin.-1997.-Vol.-47(3).-P. 171−190.
- Baxter N.N., Virnig B.A., Durham S.B., et al. Trends in the treatment of ductal carcinoma in situ of the breast // J. Natl. Cancer Inst.-2004.-Vol. 96.-P. 443−8.
- Beahrs O.H., Henson D.E., Hutter R.V. Manual for staging of cancer//ed 4, Philadelphia // J.B. Lippincott.-1992.-P. 149−154.
- Bellamy C.O., McDonald C., Salter D.M., et al. Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization // Hum. Pathol.-1993.-Vol.24.-P. 16−23.
- Beron P., Lewinsky B.S., Silverstein M.J. Van Nuys experience with excision plus radiation therapy // Silverstein M.J. (Ed.) Ductal carcinoma in situ of the breast.- Baltimore: Williams and Wilkins, 1997.-P. 405−409.
- Bethwaite P., Smith N., Delahunt В., et al. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast // J. Clin. Pathol. 1998.-Vol. 51.-P. 450−454.
- Betsill W.L. Jr., Rosen P.P., Lieberman P.H., et al. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone // JAMA.-1978.-Vol. 239.-P. 1863−7.
- Bijker N., Peterse J.L., Duchateau L. et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ- Analysis of EORTC trial 10 853 // EJC.-2000.-Vol. 36. (Suppl.5).-Abstr. 120.
- Boland GP, Butt IS, Prasad R, et al. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ // Br. J. Cancer.-2004 Jan.-Vol. 90, N2.-P. 423−9.
- Boland GP, McKeown A, Chan КС, Prasad R, Knox WF, Bundred NJ. Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast. Br J Cancer. 2003 Jul 21−89(2):277−83.
- Bornstein B.A., Recht A., Connolly J.L., et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy // Cancer.-1991.-Vol. 67.-P. 7−13.
- Boyages J., Delaney G., Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis//Cancer.-1999.-Vol.85.-P.616−628.
- Britton P.D. Fine needle aspiration or core biopsy for impalpable breast lesions?// The Breast.-1999.-Vol.8.(l)-P.l-4.
- Britton P.D., McCann J. Needle biopsy in the NHS Breast Screening Programme 1996/97: how much and how accurate?// The Breast.-1999.-VoL8.-P.5-ll.
- Brown P.W., Silverman J., Owens E. et al. Intraductal «noninfiltrating» carcinoma of the breast / /Arch. Surg.-1976.-Vol. 11 l.-P. 1063−1067.
- Bur ME, Zimarowski MJ, Schnitt SJ, et al. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast // Cancer.-1992.-Vol. 69.-P. 1174−81.
- Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: Improved accuracy with directional, vacuum-assisted biopsy // Radiology.-1997.-Vol. 202.-P. 843−847.
- Burbank F. Stereotactic breast biopsy: its history, its presents, its future//Am. Surg.-1996.-Vol.62.-P.128−150.
- Burbank F., Parker S.H., Fogarty T.J., et al. Stereotactic breast biopsy: improved tissue harvesting with the Mammotome//Am. J. Surg.-1996.-Vol.62.-P.739−744.
- Bush D.S., Remington P.L., Reeves M., et al. In situ breast cancer correlates with mammography use, Wisconsin: 1980−1992 // Wis. Med. J.-1994.-Vol. 93.-P. 483.
- Carpenter R., Boulter P. S. Cooke Т., et al. Management of screen detected ductal carcinoma in situ of the female breast // Br. J. Surg.-1989.-Vol. 76.-P. 564−567.
- Carter D., Smith R.R. Carcinoma in situ of the breast // Cancer.-1977.-Vol. 40.-P. 1189−1193.
- Cataliotti L., Distante V., Pacini P., et al. // Silverstein M.J. (Ed.) Ductal carcinoma in situ of the breast.-Baltimore: Williams and Wilkins, 1997.-P. 449−454.
- Cheatle G.L., Cutler M. Tumors of the breast // Philadelphia: J.B. Lippincott.-1931.
- Coombs JH, Hubbard E. Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with the extent of disease // Am. Surg.-1997.-Vol. 63 .-P. 1079−1086.
- Cornil A.V. Les Tumeurs du Sein // Paris: Libraire Germer Bailliere and Company.-1908.
- Cross M.G., Evans W.P., Peters G.N., et al. Stereotactic breast biopsy as an alternative to open excisional biopsy//Ann. Surg. Oncol.-1995.-Vol.2.-P.195−200.
- Cutuli В., Mignotte H., De Lafontan B. et al. Outcome after local recurrence in women with for ductal carcinoma in situ // EJC.-2000.-Vol. 36.(Suppl.5).-Abstr. 121.
- Cytology subgroup of the National Coordinating Committee for Breast Screening Pathology: guidelines for cytology procedures and reporting in breast cancer screening// UK-NHSBSP Screening, September.-1993.-P.22.
- Daniel B.L., Yen Y.F., Glover G.H., et al. Breast disease: Dynamic spiral MR imaging // Radiology.-1998.-Vol. 209.- P. 499−509.
- De Roos MA, Pijnappel RM, Post WJ, De Vries J, Baas PC, Groote LD. Correlation between imaging and pathology in ductal carcinoma in situ of the breast. World J Surg Oncol. 2004 Mar 12−2(1):4.
- Dent D.M., Kirkpatrick A.E., McGoogan E., et al. Stereotactic localisation and aspiration cytology of impalpable breast lesions//Clin. Radiol.- 1989.-Vol.40.-P.380−382.
- Dershaw D.D. Mammography in patients with breast cancer treated by breast conservation (lumpectomy with or without radiation) // AJR.-1995.Vol. 164.-P. 309−316.
- Dershaw D.D., Abramson A., Kinne D.W. Ductal carcinoma in situ: Mammographic findings and clinical implications // Radiology.-1989.-Vol. 170.-P. 411—415.
- Dinkel H., Gassel A., Tschammler A.: Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ // Br. J. Radiol.-2000.-Vol. 73.-P. 938−944.
- Distante V., Casella D., Orzatesi L. Ductal carcinoma in situ//EJSO.-2004 March.-Vol.30.-P.122.
- Early Breast Cancer Trialist’s Collaborative Group. Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer//The Lancet.-2000.-Vol.355.-P. 1757−1770.
- Elliott A.J., Cooke J.C., МеКее G. A 4-year retrospective analysis of screen-detected and stereotactically biopsied microcalcification with emphasis on ways to reduce the number of benign surgical biopsies//The Breast.-1996.-Vol.5 .-P.410−415.
- Ernster V.L., Barclay J., Kerlikowske K., et al. Incidence of and treatment for ductal carcinoma in situ of the breast // JAMA.-1996.-Vol. 275.-P. 913−8.
- Eusebi V., Feudale E., Foschini M.P., et al. Long-term follow-up of in situ carcinoma of the breast // Semin. Diagn. Pathol.-1994,-Vol. 1 l.-P. 223−35.
- Evans A., Pinder S., Ellis I., et al. Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation//Radiology.- 1994.-Vol. 191.-P. 237−240.
- Evans A., Pinder S., Wilson R., et al. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings // Am. J. Radiol.-1994.-Vol. 162.-P. 1307−1311.
- Evans A. The diagnosis and management of pre-invasive breast disease: radiological diagnosis. Breast Cancer Res. 2003−5(5):250−3.
- Ewing J. Neoplastic Diseases // (Ed. 1), Philadelphia: WB Saunders, 1919.
- Farkas EA, Stolier AJ, Teng SC, et al. An argument against routine sentinel node mapping for DCIS // Am. Surg.-2004 Jan.-Vol. 70, N1.-P. 13−7.-Discussion 17−18.
- Farrow J.H. Current concepts in the detection and the treatment of the earliest of the early breast cancers // Cancer.-I970.-Vol. 25.-P. 468 477.
- Faverly D.R., Burgers L., Bult P., et al. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications // Semin DiagnPathol.-1994.-Vol. 11.-P. 193−198.
- Fechner R.E. Infiltrating lobular carcinoma without lobular carcinoma in situ // Cancer.-1972.-Vol. 29.-P. 1539−1545.
- Findlay P., Goodman R. Radiation therapy for treatment of intraductal carcinoma of the breast // Am. J. Clin. Oncol.-1983.-Vol. 6.-P. 281 285.
- Fisher В., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer //N. Engl. J. Med.-2002.-Vol. 347.-P. 1233−41.
- Fisher В., Constantino J. P, Wickerham D.L., et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-l Study// J. Natl. Cancer Inst.-1998.-Vol.90.-P. 1371−1388.
- Fisher В., Costantino J., Redmond C. et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer //N. Engl. L. Med.-1993.-Vol. 328.-P. 1581−1586.
- Fisher В., Dignam J., Wolmark N., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from NSABP B-17 // J. Clin. Oncol.-1998.-Vol. 16.-P. 441−452.
- Fisher В., Dignam J., Wolmark N., et al. Tamoxifen in treatment of intraductal breast cancer: NSABP B-24 randomized controlled trial // Lancet.-1999.-Vol. 353.-P. 1993-. 2000.
- Fisher В., Jeong J.H., Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation // N. Engl. J. Me.-2002.-Vol.347.-P. 567−575.
- Fisher В., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience // Semin. Oncol.-2001.-Vol.-28.-P. 400−418.
- Fisher В., Redmond C., Poisson R. et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer // N. Engl J. Med.-1989.-Vol. 320.-P. 822−828.
- Fisher E.R., Costantino J., Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ) // Cance.-1995.-Vol. 75.-P. 1310−1319.
- Fisher E.R., Dignam J., Tan-Chiu E., Costantino J. Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of Protocol B-17 // Cancer.-1999.-Vol. 86, N 3.-P. 429−438.
- Fisher E.R., Leeming R., Anderson S, et al: Conservative management of intraductal carcinoma (DCIS) of the breast // J. Surg. Oncol.-1991.-Vol. 47-P. 139−147.
- Fisher E.R., Sass R., Fisher B. et al. Pathologic findings from the NSABP (Protocol 6). II. Relation of local breast recurrence to multicentricity//Cancer.-1986.-Vol. 57.-P. 1717−1724.
- Foote F.W., Stewart F.W. Lobular carcinoma in situ: a rare form of mammary carcinoma // Am. J. Pathol.-1941.-Vol. 17.-P. 491−495.
- Forrest A.P., Stewart H.J., Everington D., et al. Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group // Lancet.-1996.-Vol. 348.-P. 708−713.
- Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology. 2004 Jun-231(3):813−9.
- Fourquet A., Zafrani В., Campana F., et al. Breast conserving treatment of ductal carcinoma in situ // Semin. Radiat. Oncol.- 1992.-Vol. 2.-P. 116−124.
- Fowble В., Hanlon A.L., Fein D.A., et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ //Abstr. Int. J. Radiat. Oncol. Biol. Phys.-1996.-Vol.36.-P. 213.
- Fracchioli S., Bellino R., Arisio R., et al. Ductal carcinoma in situ
- DCIS): USC/Van Prognostic Index (VNPI) and the impact oftlimicropapillary histotype//40 American Society of Clinical Oncology Annual Meeting, New Orleans, June 5−8, 2004,-abstract 662.-P.42.
- Frazier T.G., Copeland E.M., Gallager H.S. et al. Prognosis and treatment in minimal breast cancer // Am. J. Surg.-1977.-Vol. 133.-P. 697−701.
- Frykberg E.R., Bland K.I. Overview of the biology and management of ductal carcinoma in situ of the breast // Cancer.-1994.-Vol. 74 (Suppl 1).-P. 350−61.
- Frykberg E.R., Santiago F., Betsill W.L. et al. Lobular carcinoma in situ of the breast// Surg. Gynevol. Obstet.-1987.-Vol.164.-P. 285−301.
- Gallagher H.S., Martin J.E. An orientation to the concept of minimal breast cancer // Cancer.-1971.-Vol. 28.-P. 1505−1507.
- Gallagher H.S., Martin J.E. Early phases in the development of breast cancer // Cancer.-1969.-Vol. 28.-P. 1170−1178.
- Gallagher W.J., Koemer F.C., Wood W.C. Treatment of intraductal carcinoma with limited surgery: long-term follow-up // J. Clin. Oncol.-1989.-Vol.7.-P. 376−80.
- Gilles R., Zafrani В., Guinebretiere J.M., et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation // Radiology.- 1995.-Vol. 196.- P. 415−419.
- Godwin J.T. Chronology of lobular carcinoma of the breast: report of a case // Cancer.-1952.-Vol. 5.-P. 229−266.
- Goldstein N., Vicini F., Kestin L., et al. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age // Cancer.-2000.-Vol. 88.-P. 2553 -2560.
- Graham M.D., Lakhani S., Gazet J.C. Breast conserving surgery in the management of in situ breast carcinoma // Eur. J. Surg. Oncol.-1991.-Vol. 17.-P. 258−64.
- Griggs J.J., Sorbero M.E.S., Sattelberg K., et al. Does detection andiLtreatment of ductal carcinoma in situ prevent invasive cancer?// 40 American Society of Clinical Oncology Annual Meeting, New Orleans, June 5−8,2004.-abstract 664.-P.42.
- Guidi A.J., Fischer L., Harris J.R., Et al. Microvessel density and distribution in ductal carcinoma in situ of the breast // J. Natl. Cancer Inst.-1994.-Vol. 86.-P. 614−619.
- Gump F.E., Jicha D.L., Ozello L. Ductal carcinoma in situ: A revised concept//Surgery.-1987.-Vol. 102.-P. 790−795.
- Haagensen C.D. Diseases of the breast // (Ed. 3).-Philadelphia: WB Saunders.-1986.-P. 192−241.
- Haffty B.G., Peschel R.E., Papadopoulos D. et al. Radiation therapy for ductal carcinoma in situ of the breast // Connecticut Medicine.-1990.-Vol. 54.-P. 482−484.
- Harter L.P., Curtis J.S., Ponto J., et al. Malignant seeding of the needle track during stereotaxic core needle breast biopsy//Radiology.-1992.-Vol. 185(3).-P.713−714.
- Hassell P.R., Olivotto I.A., Mueller H.A., et al. Early breast cancer: detection of recurrence after conservative surgery and radiation therapy // Radiology.-I990.-Vol. 176.-P. 731−735.
- Hata T, Takahashi H, Watanabe K, Takahashi M, Taguchi K, Itoh T, Todo S. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg. 2004 Feb- 198(2): 190−7.
- Hermann G, Keller R, Drossman S, et al. Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation // Can. Assoc. Radiol. J.-1999.-Vol.50.-P. 235−240.
- Hetelekidis S., Collins L., Silver B. et al. Predictors of local recurrence following excision alone for ductal carcinoma in situ // Cancer.-1999.-Vol. 85.-N. 2.-P. 427−431.
- Hetelekidis S., Schnitt S.J., Morrow M., Harris J.R. Management of ductal carcinoma in situ // Cancer Journal for Clinicians.-1995.-Vol. 45.-P. 244−253.
- Hillner B.E., Desch C.E., et al. Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast//J. Clin. Oncol.- 1996.-Vol. 14.-P. 70−7.
- Hiramatsu H., Bornstein B.A., Recht A., et al. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ.
- Possible importance of family history I I Cancer J. Sci. Am.-1995.-Vol.1.-P. 55−61.
- Holland R, Hendricks J. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation // Semin. Diagn. Pathol.-1994.-Vol. 11.-P. 181−192.
- Holland R. New aspects and pitfalls in the diagnosis of breast cancer // Thesis.- Nijmegen.-1994.-P. 79−109.
- Holland R., Faverly D.R. Whole-organ studies // Silverstein M.J. (Ed.) Ductal carcinoma in situ of the breast.-Baltimore: Williams & Wilkins, 1997.-P. 233−240.
- Holland R., Hendricks J.H., Verbeck A.L. et al. Extent, distribution, and mammographic/histologic correlations of breast ductal carcinoma in situ // Lancet.-1990.-Vol. 335.-P. 519−522.
- Holland R., Peterse J.L., Millis R.R. et al. Ductal carcinoma in situ: A proposal for a new classification//Semin Diagn Pathol.-1994.-Vol. 11.-P. 167−180.
- Hwang E.S., Kinkel K., Esserman L.J., et al. Magnetic resonance imaging in patient diagnosed with ductal carcinoma-in-situ: value inthe diagnosis of residual disease, occult invasion, and multicentricity//Ann. Surg. Oncol.-2003.-Vol.l0(4).-P.381−388.
- Hwang ES, Esserman L. Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results. Ann Surg Oncol. 2004 Jan- 11(1 Suppl):37S-43S.
- Intra M., Zurrida S., Maffini F., et al. Sentinel lymph node metastasis in microinvasive breast cancer // Ann. Surg. 0ncol.-2003 Dec.- Vol. 10, N10.-P. 1160−5.
- Jackman R.J., Burbank F., Parker S.H., et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates // Radiology.- 2001 .-Vol. 218.-P. 497−502.
- Jackman R.L., Nowels K.W., Shepard M.J., et al. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia // Radiology.-1994.-Vol. 193.-P. 91−95.
- Jacobson J. A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of Stage I and II breast cancer // N. Engl. J. Med.-1995.-Vol. 332.-P. 907−911.
- Julien J.P., Bijker N., Fentiman I.S., et al. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: First results of the EORTC randomized phase III trial 10 853 // Lancet.-2000.-Vol. 355.-P. 528−533.
- Katz S.J., Lantz P.M., Zemencuk J.K. Correlates of surgical treatment type for women with noninvasive and invasive breast cancer // J. Womens Health Gend. Based Med.- 2001.-Vol. 10.-P. 659−70.
- Kerin M.J., Williams N.N., Cronin K.J. et al. Stereotactic cytology in a regional breast-screening programme//Br. J. Surg.-1994.-Vol.81.-P.221−222.
- Kerlikowske K., Molinaro A., Cha I., et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy // J. Natl. Cancer Inst.-2003 Nov. 19.- Vol. 95, N 22.-P. 1692−702.
- Khan A, Newman LA. Diagnosis and management of ductal carcinoma in situ. Curr Treat Options Oncol. 2004 Apr-5(2):131−44.
- Kiel KD. Management of Tla breast cancer. Clin Breast Cancer. 2004 Apr-5(l):43−51.
- Killeen D.M., Fraser F., Leinster L.S. et al. The effect of stereotactic fine needle aspiration biopsy on the management of impalpable breast lesions// The Breast.- 1994.-Vol.3.-P.l73−176.
- Kinne D.W., Petrek J.A., Osborne M.P., et al. Breast carcinoma in situ //Arch. Surg.- 1989.-Vol. 124.-P. 33−36.
- Kraus F.T., Neubecker R.D. The differential diagnosis of papillary tumors of the breast // Cancer.-1962.-Vol. 15.-P. 444−455.
- Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions? // Radiology.-1999.-Vol. 211.-P. 1−10.
- Kurtz J.M., Jacquemier J., Torhorst J., et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma // Cancer.-1989.-Vol. 63.-P. 1630−1635.
- Kuske RR, Bean JM, Garcia DM, et al. Breast conservation therapy for intraductal carcinoma of the breast // Int. J. Radiat. Oncol. Biol Phys.-1993.-Vol. 26.-P. 391−396.
- Lagios M.D. Ductal carcinoma in situ: biological and therapeutic implications of classification // The Breast Journal.-1996.-Vol. 2.-N 2.-P. 32−34.
- Lagios M.D. Ductal carcinoma in situ: biological implications for clinical practice // Seminars in Oncology.-1996.-Vol. 23.-N l.-P. 6−11.
- Lagios M.D. Ductal carcinoma in situ: Controversies in diagnosis, biology, and treatment // The Breast J.-1995.-Vol. 1, N 2.-P. 68−78.
- Lagios M.D. Ductal carcinoma in situ: Pathology and treatment // Surgical Clinics of North America.-I990.-Vol. 70, N 4.-P. 853−871.
- Lagios M.D. Heterogeneity of ductal carcinoma in situ: Relationship of grade and subtype analysis to local recurrence and risk of invasive transformation // Cancer Letters.-1995.-Vol. 90.-P. 97−102.
- Lagios M.D. Lagios experience // Silverstein M.J. (Ed.) Ductal carcinoma in situ of the breast.-Baltimore: Williams and Wilkins, 1997.-P. 363−364.
- Lagios M.D., Margolin F., Westdahl P. et al. Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence//Cancer.- 1989.-Vol. 63.-P. 618−624.
- Lagios M.D., Silverstein M.J. Ductal carcinoma in situ // Surgical Oncology Clinics of North America.- 1997.-Vol. 6.-N 2.-P. 385−392.
- Lagios M.D., Westdahl P.R., Rose M.R. The concept and implications of multicentricity in breast carcinoma // Path Ann.-1981.-Vol. 2.-P. 83 102.
- Lagios MD, Page DL. A critical appraisal of NSABP-B17, a randomized trial of irradiation of duct carcinoma in situ. Quarterly Review // Current Perspectives on Breast Cancer.-1994.-Vol. 1.
- Lagios MD. Heterogeneity of ductal carcinoma in situ of the breast // J. Cell. Biochem.-1993.-Vol. 17G (Suppl.).-P. 49−52.
- Lanyi M. Diagnosis and differential diagnosis of breast calcifications // Springer-Verlag, New York, NY.-1986.-Vol. 91.-P.107.
- Lara J.F., Young S. M, Velilla RE, et al. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up // Cancer.-2003 Nov. 15.-Vol. 98, N10.-P. 2105−13.
- Lattes R. Lobular neoplasia (lobular carcinoma in situ) of the breast- a histological entity of controversial clinical significance // Pathol. Res. Pract.-1980.-Vol. 166.-P. 415−429.
- Lennington W.J., Jensen R. A, Dalton L.W., et al. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions // Cancer -1994.-Vol. 73.-P. 118−24.
- Liberman L., Dershaw D.D., Rosen P.P. Stereotaxic 14-gauge breast biopsy: How many core biopsy specimens are needed?// Radiology.-1994.-Vol. 192.-P.793−795.
- Litherland J.C., Evans A. J., Wilson A.R., et al. The impact of core biopsy on pre-operative diagnosis of screen detected breast cancers//Clin. Radiol.-1996.-Vol.-51(8).-P.562−565.
- Liu E, Thor A, He M, et al. The HER2 (c-erbB-2) oncogene is frequently amplified in situ carcinomas of the breast // Oncogene.-1992Vol. 7.-P. 1027−32.
- Ma X.J., Salunga R., Tuggle J.T., et al. Gene expression profiles of human breast cancer progression // Proc. Natl. Acad. Sci. USA.- 2003.-Bol.100.-P. 5974−9.
- Maluf HM. Differential diagnosis of solid carcinoma in situ. Semin Diagn Pathol. 2004 Feb-21(l):25−31.
- Mamounas E., Fisher В., Dingam J., et al. Effects of breast irradiation following lumpectomy in intraductal carcinoma (DCIS): Updated results from NSABP B-17 // Proc. Soc. Surg. Oncol.-1997.-Vol. 50.P. 7.
- Margolin F.R., Lagios M.D. Mammographic detection of early breast cancer: Ten years' experience in a community hospital // West. J. Med.-1986.-Vol. 144.-P. 46−48.
- McCormick В., Rosen P., Kinne D. et al. Duct carcinoma in situ of the breast: An analysis of local control after conservation surgery and radiotherapy // Int J Radiat Oncol Biol Phys.-1991.-Vol. 21.-P. 289 292.
- McMasters K.M., Chao C., Wong S.L., et al. Sentinel lymfh node biopsy in patients with ductal carcinoma in situ: a proposaV/Cancer.-2002 Jul. 1 -Vol.95(l).-P. 15−20.
- Meyer J.S. Cell kinetics of histologic variants of in situ breast carcinoma // Breast Cancer Res. Treat.-1986.-Vol. 7.-P. 171−180.
- Mikhail R. A., Nathan R.C., Tummala R.M., et al. Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy//Annals of Surgical Oncology.-1994.-Vol.l.-P.363−367.
- Miller AR, Brandao G, Prihoda TJ, Hill C, Cruz AB Jr, Yeh IT. Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates. J Surg Oncol. 2004 Jun 1−86(3):134−40.
- Millis RR, Pinder SE, Ryder K, Howitt R, Lakhani SR. Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast. Br J Cancer. 2004 Apr 19−90(8): 1538−42.
- Mirza N.Q., Vlastos G., Meric F., et al. Ductal carcinoma-in situ: Long-term results of breast conserving therapy // Ann. Surg. Oncol.-2000Vol. 7.-P. 656−664.
- Mitra S.S., Salman A., Bloomfield D., et al. A retrospective review of wide excision alone for ductal carcinoma in situ (DCIS) of the breast//40th American Society of Clinical Oncology Annual Meeting, New Orleans, June 5−8, 2004,-abstract 785.-P.72.
- Mokbel K. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects // Int. J.Fertil. Womens Med.-2003 Sep-Oct.-Vol. 48, N5.-217−25.
- Morrow M, Bucci C, Rademaker A. Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 1998- 186:269−74.
- Morrow M, Venta LA, Stinson T, et al. A prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg 2001−233:537−541.
- Nakamura S, Woo C, Silberman H, Streeter OE, Lewinsky BS, Silverstein MJ. Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy .Am J Surg.2002 Nov-184(5):403−9.
- Nakhlis F, Morrow M. Ductal carcinoma in situ. Surg Clin North Am.2003 Aug-83(4):821−39.
- Norris H.J., Bahr G.F., Mikel U.V. A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast// Anal Quant Cytol Histol.-1987.-Vol. 10.-P. 19.
- Orel SG, Fowble BL, Solin LJ, et al. Breast cancer recurrence after lumpectomy and radiation therapy for early-stage prognostic significance of detection method. Radiology 1993- 188:189.
- Orel SG, Mendonca MH, Reynolds C, et al. MR imaging of ductal carcinoma in situ. Radiology 1997−202:413−420.
- Orel SG, Troupin RH, Patterson EA, et al. Breast cancer recurrence after lumpectomy and irradiation: Role of mammography in detection. Radiology 1992−183:201−206.
- Ottesen GL, Graversen HP, Blichert-Toft M, et al: Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 16:1183−1196, 1992.
- Ozzello L., Sanpitak P. Epithelial-stromal junction of intraductal carcinoma of the breast//Cancer.-1971.-Vol. 26.-P. 1186−1198.
- Page D, Anderson T (eds): Diagnostic Histopathology of the Breast, pp 157−174. NewYork, Churchill Livingstone, 1987.
- Page D.L., Dupont W.D., Rogers L.W. et al. Continued local recurrence of carcinoma 15 025 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy//Cancer.-1995.-Vol. 76.-P. 1197−1200.
- Page D.L., Kidd Т.Е., Dupont W.D. et al. Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease//Hum Pathol.-1991.-Vol. 22.-P. 1232−1239.
- Page D.L., Rogers L.W. Combined histologic and citologic criteria for the diagnosis of mammary atypical ductal hyperplasia//Hum Pathol.-1992.-Vol. 23.-P. 1095−1097.
- Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982−49:751−8.
- Pallis L, Wilking N, Cedermark B, Rutqvist LE, Skoog L. Receptors for estrogen and progesterone in breast carcinoma in situ. Anticancer Res. 1992−12:2113−5.
- Parker S.H., Lovin J.D., Jobe W.E., et al. Non-palpable breast lesions: stereotactic automated large-core biopsies//Radiology.-1991.-Vol. 180.-P.403−407.
- Parker S.H., Lovin J.D., Jobe W.E., et al. Stereotactic breast biopsy with a biopsy gun//Radiology.-1990.-Vol.l76.-P.741−747.
- Patchefsky A.S., Schwartz G.F., Finkelstein S.D. et al. Heterogeneity of intraductal carcinoma of the breast//Cancer.-1989.-Vol. 63.-P. 731 741.
- Pendas S, Dauway E, Guiliano R, et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000−7:15−20.
- Pijnappel RM, van den Donk M, Holland R, Mali WP, Peterse JL, Hendriks JH, Peeters PH. Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions. Br J Cancer. 2004 Feb 9−90(3):595−600.
- Pinder SE, Ellis IO. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)—current definitions and classification. Breast Cancer Res. 2003−5(5):254−7.
- Pollei S.R., Mettler F.A., Bartow S.A. Occult breast cancer: Prevalence and radiographic detectability//RadioIogy.-1987.-Vol. 163.-P. 459−462.
- Poller D, Silverstein MJ: The Van Nuys Ductal Carcinoma In Situ Classification: An Update, in Silverstein MJ, Recht A, Lagios MDeds): Ductal Carcinoma In Situ of the Breast, pp 222−233. Philadelphia, Lippincott Williams & Wilkins, 2002.
- Poller D.N., Roberts E.C., Bell J.A. et al. p53 protein expression in mammaiy ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein//Hum Pathol.-1993.-Vol. 24.-P. 463−468.
- Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, et al. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 2003- 1: 362−75.
- Price P, Sinnett HD, Gusterson B, Walsh G, A’Hem RP, McKinna JA. Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone. Br J Cancer. 1990−61:869−72.
- Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE. Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study Pathology. 2004 Jun-36(3):221−9.
- Qualheim R.E., Gall E.A. Breast carcinoma with multiple sites of origin//Cancer.-l 957.-Vol. 10.-P. 460−468.
- Ray GR, Adelson J, Hayhurst E, et al. Ductal carcinoma in situ of the breast: Results of treatment by conservative surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 1993−28:105−111.
- Recht A., Danoff B.S., Solin L.G. et al. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and radiation//J Clin Oncol.-1985.-Vol. 3.-p. 1339−1343.
- Robinson I.A., McKee G. Cytological performance in palpable versus stereotactically sampled breast lesions//The Breast.-1996.-Vol.5.-P.415−418.
- Rodriguez N, Sanz X, Algara M, Foro P, Aunon C, Morilla I, Reig A, Ferrer F. Conservative treatment in noninvasive breast cancer.Tumori. 2004 Jan-Feb- 90(1): 17−21.
- Roka S., Rudas M., Taucher S., et al. High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS//EJSO.-2004.-Vol.30.-P.243−247.
- Rosen P.P. Axillary lymph node metastases in patients with occult noninvasive breast carcinoma//Cancer.-1980.-Vol. 46.-P. 1289−1306.
- Rosen P.P. Lobular carcinoma in situ and intraductal carcinoma of the breast//Monogr Pathol.-1984.-Vol. 25.-P. 59−105.
- Rosen P.P. The clinical significance of pre-invasive breast cancer//Cancer.-1980.-Vol. 46.-P. 919−925.
- Rosen P.P., Braun D.W., Lyngholm B. et al. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral masectomy and contralateral breast biopsy//Cancer.-1981.-Vol. 47.-P. 813−819.
- Rosen P.P., Lieberman P.H., Braun D.W. et al. Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years//Am J Surg Pathol.-1978.-Vol. 3.-P. 225−251.
- Rubio I., Mirza N., Sahin A. et al. Role of specimen radiograph in patient treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast // ASCC).-2000.-Abstr. on CD-ROM.-Abstr. 346.
- Rudas M., Neumayer R., Gnant M.F., et al. p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast//Eur. J. Cancer.-1997.-Vol.33.-P.39−44.
- Sacorafas G.H., Tsiotou A.G. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives//Caner Treat. Rev.-2000 Apr.-Vol.26(2).-P. 103 -125 .-Review.
- Sakorafas GH, Farley DR. Optimal management of ductal carcinoma in situ of the breast. Surg Oncol. 2003 Dec- 12(4):221−40.
- Salvadori В., Delledonne V., Rovini D. National Cancer Institute-Milan experience // Silverstein M.J. (Ed.) Ductal carcinoma in situ of the breast.-Baltimore: Williams and Wilkins, 1997.-P. 427−432.
- Sawai Y., Arisawa J., Inaji H. et al. Ductal carcinoma in situ of the breast: Features of three-dimensional fat suppressed dynamic MR imaging with pathologic correlations // EJC.-2000.-Vol. 36 (Suppl. 5).-Abstr. 119.
- Schnitt S.J., Connolly J.L. Processing and evaluation of breast excision specimens. A clinically oriented approach // Am. J. Clin. Pathol.-1992.-Vol.98.-P. 125−137.
- Schnitt S.J., Connolly J.L., Tavassoli F.A., et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria // Am. J. Surg. Pathol.- 1992.-Vol. 16.-P.l 133−43.
- Schnitt S.J., Harris J.R., Smith B.L. Developing a prognostic index for ductal carcinoma in situ of the breast: are we there yet? // Cancer.1996.-Vol. 77.-P. 2189−2192.
- Schuh M.E., Nemoto Т., Penetrante R., et al. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease // Arch. Surg.-1986.-Vol. 121.-P. 1303−1307.
- Schwarts G.F., Solin L.J., Olivotto I.A., et al. The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22−25, 1999 // The Breast Journal.-2000.-Vol. 6.-N l.-P. 4−13.
- Schwartz G.F. Treatment of subclinical ductal carcinoma in situ by excision and local surveillance // Silverstein M.J. (Ed.) Ductal carcinoma in situ of the breast.-Baltimore: Williams and Wilkins, 1997.-P. 353−360.
- Schwartz G.F., Finkel G.C., Garcia J.C. et al. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone // Cancer.-1992.-Vol. 70.-P. 2468−2474.
- Schwartz G.F., Solin L J., Olivotto I.A. The consensus conference on the treatment of in situ ductal carcinoma of the breast // Hum. Pathol.-2000.-Vol.31.-P. 131−139.
- Schwartz G.F.: The role of excision and surveillance alone in subclinical DCIS of the breast // Oncology.-1994.-Vol.8.-P.21−26.
- Scott M.A., Lagios M.D., Axelsson K., et al. Ductal carcinoma in situ of the breast: Reproducibility of histologic subtype analysis // Hum. Pathol.-1997.-Vol.28. P. 967−973.
- Shoker B.S., Sloane J.P.: DCIS grading schemes and implications // Histopathology.-1999.-Vol. 35.-P. 393−400.
- Shreer I. Conservation therapy of DCIS without radiation // Breast Disease.-1996.-Vol. 9.-P. 27−36.
- Sibbering D.M., Blarney R.W. Nottingham experience // Silverstein M.J. (Ed.) Ductal carcinoma in situ of the breast.-Baltimore: Williams and Wilkins.-1997.-P.367−372.
- Sibbering D.M., Ellis I.O., Obuszko Z., et al. Is radiotherapy necessary in adequately excised ductal carcinoma in situ (DCIS)? // J. Pathol.-1996.-Vol.178 (Suppl).-Abstr.
- Sickles E. A. Further experience with microfocal spot magnification mammography in the assessment of clustered breast microcalcifications // Radiology.-1980.-Vol. 137 N9-P.14.
- Sickles E.A. Breast calcifications: Mammographic evaluation // Radiology.-1986.-Vol. 160.-P. 289−293.
- Sickles E.A. Mammographic detectability of breast microcalcifications //AJR.-1982.-Vol. 139.-P. 913−918.
- Sigal-Zafrani В., Lewis J.S., Clough K.B., et al. Histological margin assessment for breast ductal carcinoma in situ: precision and implications // Mod. Pathol.-2004 Jan.-Vol. 17(1).- P. 81−88.
- Sigfiisson .1, Aspergren K., Janzon L., et al. Clustered breast calcifications // Acta. Radiol. (Diagn.) (Stockh.).-1983.-Vol. 24.-P. 273−281.
- Silverstein M.J. An argument against routine use of radiotherapy for ductal carcinoma in situ // Oncology.-2003.-Vol. 17.-P. 1−23.
- Silverstein M.J. Lagios M.D. Use of predictors of recurrence to plan therapy for DCIS of the breast // Oncology.-1997.-Vol. 11.-N. 3.-P. 393−410.
- Silverstein M.J. Lagios M.D., Groshen S. et al. The influence of margin width on local control of ductal carcinoma in situ of the breast// N. Engl. J. Med.-1999.-Vol. 340.-N 19.-P. 1455−1461.
- Silverstein M.J. Van Nuys experience by treatment // Silverstein M.J. // (Ed.) Ductal carcinoma in situ of the breast.-Baltimore: Williams and Wilkin.-1997.-Vol. 47.-P. 443−448.
- Silverstein M.J., Barth A., Poller D.N., et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast // Eur. J. Cancer.-1995.-Vol. 31A.-P. 1425−1427.
- Silverstein M.J., Cohlan B.F., Gierson E.D., et al. Duct carcinoma in situ: 228 cases without microinvasion // Eur. J. Cancer.-1992.-Vol.28.-P.630−634.
- Silverstein M.J., Lagios M.D., Craig P.H. et al. A prognostic index for ductal carcinoma in situ of the breast // Cancer.-1996.-Vol. 77.-P. 1167−1174.
- Silverstein M.J., Lagios M.D., Craig P.H., et al: The Van Nuys Prognostic Index for ductal carcinoma in situ // Breast J.-1996.-Vol. 2.-P. 38−40.
- Silverstein M.J., Lagios M.D., Martino S. et al. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast // J. Clin.Oncol.-1998.-Vol. 16.-N. 4.-P. 1367−1373.
- Silverstein M.J., Poller D.N., Waisman J.R. et al. Prognostic classification of breast duct carcinoma in situ // Lancet.-1995.-Vol. 345.-P. 1154−1157.
- Silverstein M.J., Waisman J.R., Gamagami P. et al. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice//Cancer.-1990.-Vol. 66.-P. 102−108.
- Silverstein M.J.: The Van Nuys/USC experience by treatment // Silverstein M J., Recht A., Lagios M.D. (Eds). Ductal Carcinoma in Situ of the Breast.-Philadelphia Lippincott: Williams & Wilkins, 2002.-P. 337−342.
- Silverstein MJ. Ductal carcinoma in situ of the breast. Annu Rev Med. 2000−51:17−32.
- Skinner KA, Silverstein MJ. The management of ductal carcinoma in situ of the breast. Endocr Relat Cancer. 2001 Mar-8(l):33−45.
- Skjorten F., Amlie E., Larsen K.A. On the occurrence of focal, occult in situ and invasive carcinoma in 250 mastectomy specimens // Eur. J. Surg. Oncol.-1986.-Vol.l2.-P.l 17−21.
- Slanetz P.J., Giardino A.A., Oyama Т., et al. Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype // Breast J.-2001.-Vol.7.-P. 417−421.
- Sneige N., Lagios M.D., Schwarting R., et al. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ // Hum. Pathol.- 1999.-Vol.30.-P.257−262.
- Sneige N., McNeese M.D., Atkinson E.N. et al. Ductal carcinoma in situ treated with lumpectomy and irradiation: Histopathological analyses of 49 specimens with emphasis on risk factors and long term results // Hum. Pathol.-1995.-Vol.26.-P.642−649.
- Solin L.J., Fowble B.L., Schultz D.J., et al. Definitive irradiation for intraductal carcinoma of the breast // Int. J. Radiat. Oncol. Biol. Phys.-1990.-Vol. 19.-P.843−850.
- Solin L.J., Kurtz J., Fourquet A. et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment ductal carcinoma in situ) of the breast // J .Clin. Oncol.-1996.-Vol. 14.-P.754−763.
- Solin L.J., Recht A., Fourquet A. et al. Ten year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast // Cancer.-1991.-Vol. 68.-P. 2337−2344.
- Solin L.J., Yeh I., Kurtz J. et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast with breast-conserving surgery and definitive irradiation // Cancer.-1993.-Vol.-71.-P. 2532−2542.
- Somerville J.E., Clarke L.A., Biggart J.D. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma // J. Clin. Pathol.-1992.-Vol.45.-P. 16−20.
- Stampfer M.R., Viodavsky I., Smith H.S. et al. Fibropectin production by human mammary cells // J. Natl. Cancer Inst.-1981 .-Vol. 67.-P. 253 261.
- Stomper P., Conolly J. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype // Am. J. Radiol.-1992.-Vol. 159.-P .483−5.
- Stomper P., Conolly J., Meyer J., et al. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologicpathologic correlation // Radiology.-1989.-Vol.172.-P.235−241.
- Stomper P. C, Winston J.S., Proulx G.M., et al. Mammographic detection and staging of ductal carcinoma in situ: Mammographic-pathologic correlation // Semin. Breast Dis.-2000.-Vol.3.-P.26−41.
- Stomper P.C., Connolly J.L., Meyer J.E., et al. Clinically occult ductal carcinoma in situ detected with mammography: Analysis of 100 caseswith radiographic-pathologic correlation // Radiology.-1989.-Vol.l72.-P.235−241.
- Stomper P.C., Herman S., Klippenstein D.L., et al. Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features // Radiology.-1995.-Vol.197.-P.387.
- Sunshine J.A., Moseley M.S., Fletcher W.S., et al. Breast carcinoma in situ: a retrospective review of 112 cases with a minimum 10-year follow-up//Am. J. Surg.- 1985.-Vol .150.-P.44−51.
- Swain SM: Ductal carcinoma in situ—incidence, presentation, and guidelines to treatment // Oncology.-1989.-Vol.3.-P.25−31.
- Tabar L., Gad A., Parsons W.C., et al. Mammographic appearances of in situ carcinomas // Silverstein M.J. (Ed.) Ductal carcinoma in situ of the breast.-Baltimore: Williams and Wilkins, 1997.-P. 95−117.
- Tan K.B., Yong W.P., Putti T.C. Cyclooxygenase-2 expression: a potential prognostic and predictive marker for high-grade ductal carcinoma in situ of the breast // Histopathology.-2004 Jan.-Vol. 44(1).-P.24.
- Teo N.B., Shoker B.S., Jarvis M.C. et al. Angiogenesis in ductal carcinoma in situ of the breast // EJC.-2000.-Vol. 36. (Suppl.5).-Abstr. 118.
- The Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ // Cancer.-1997.-Vol. 80.-P. 1798−1802.
- Tobon H., Price H.M. Lobular carcinoma in situ: some ultrastructural observations //Cancer.- 1972.-Vol. 30.-P. 1082−1091.
- Van de Vijver MJ, Peterse H. The diagnosis and management of preinvasive breast disease: pathological diagnosis—problems with existing classifications. Breast Cancer Res. 2003−5(5):269.
- Van Dongen J.A., Peterse J.L. Biological and clinical significance of ductal carcinoma in situ of the breast // Current perspectives in breast cancer.-New Delhi: Tata McGraw-Hill Publishing Company Limited.-1997.-P.110−114.
- Van Zee K.J., Liberman L, Samli В., et al. Long term follow-up of women with ductal carcinoma in situ treated with breast conserving surgery: The effect of age // Cancer.-1999.-Vol.86.-P. 1757−1767.
- Vicini F.A., Recht A. Age at diagnosis and outcome for women with ductal carcinoma in situ of the breast. A critical review of the literature // J. Clin. Oncol.-2002.-Vol.20.-P.2736−2744.
- Von Rueden D.G., Wilson R.E. Intraductal carcinoma of the breast //S. urg. Gynecol. Obstet.-1984.-Vol. 158.-P. 105−11.
- Walker R.A., Dearing S.J., Lane D.P., et al. Expression of p53 protein in infiltrating and in-situ breast carcinomas // J. Pathol.-1991.-Vol. 165.-P.203−11.
- Ward B.A., McKhann C.F., Ravikurmar T.S. Ten-year follow-up of breast carcinoma in situ in Connecticut // Arch. Surg.-1992.-VoI. 127.-P. 1392−5.
- Warnberg F.H., Nordgren H., Bergh J., et al. Ductal carcinoma in situ of the breast from a population-defined cohort: an evaluation of new histopatological classification systems // Eur. J. Cancer.-1999.-Vol.35.-P.714−720.
- Wellings S.R., Jensen H.M., Marcum R.G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions // J. Natl. Cancer Inst.-1975.-Vol.55.-P.231−73.
- Wells W.A., Carney P.A., Eliassen M.S., et al. Pathologists' agreement with experts and reproducibility of breast ductal carcinoma in situ classification schemes // Hum Pathol.-2000.-Vol.24.-P.651−9.
- Wheeler J.E., Enterline H.T., Roseman J.H. et al. Lobular carcinoma in situ of the breast. Long-term follow-up // Cancer.-1974.-Vol. 34.-P. 554−563.
- Williams A.B., Roberts J.V., Michell M.J., et al. Prone stereotactic breast core biopsy: the impact on surgical management of nonpalpable breast cancers//The Breast.-1999.-Vol.8.-P.12−15.
- Winchester D.P., Menck H.R., Osteen R.T., et al. Treatment trends for ductal carcinoma in situ of the breast // Ann. Surg. Oncol.-1995.-Vol.2.-P.207−13.
- Winchester D.P., Strom E.A. Standard for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast // CA Cancer J. Clin.-1998.-Vol.48.-P. 108−28.
- Wobbes Т., Tinnemans J.G., van der Sluis R.F. Residual tumour after biopsy for non-palpable ductal carcinoma in situ of the breast // Br. J. Surg.-l 989.-Vol.-76.-P. 185−6.
- Yamamoto D, Yamada M, Okugawa H, Tanaka K. Predicting invasion in mammographically detected microcalcifcation: a preliminary report. World J Surg Oncol. 2004 Apr 23−2(1):8.
- Yeoman L.J., Michell M.J., Humphreys S., et al. Radiographically guided fine needle aspiration cytology and core biopsy in the assessment of impalpable breast lesions//The Breast.-1996.-Vol.5.-P.41−47.